Histopathological spectrum of breast lesions in association with Histopathological Grade versus Estrogen receptor and Progesterone receptor status in breast cancers : A Hospital based study

Authors

  • Mohan Rao Nandam Narayana Medical College, Nellore, Andhra Pradesh, India
  • Vissa Shanthi Narayana Medical College, Nellore, Andhra Pradesh, India
  • Bhavana Grandhi Narayana Medical College, Nellore, Andhra Pradesh, India
  • Syama Sundara Rao Byna Narayana Medical College, Nellore, Andhra Pradesh, India
  • Bheemaraju Venkata Vydehi Narayana Medical College, Nellore, Andhra Pradesh, India
  • Jyothi Conjeevaram Narayana Medical College, Nellore, Andhra Pradesh, India

Keywords:

Breast lesions, Fibro adenoma, infiltrating ductal carcinoma, histopathological grade, Immunohistochemistry.

Abstract

Background:  A retrospective study of 2-years duration from January 2015 to December 2016 was undertaken to evaluate the histopathological spectrum of breast lesions including both the benign breast lesions and malignant breast lesions. To evaluate the Estrogen receptor and Progesterone receptor status in breast cancer cases by using immunohistochemistry and is to correlate the histopathological grade with ER, PR status of breast cancer.

 Methods: The histopathological findings of the 132 biopsied Specimens of all age groups and both sexes were studied and most of them were lumpectomy specimens and few were mastectomy specimens. IHC markers were applied on breast cancer cases.

Results: Out of the 132 cases benign breast lesions constituted 78.78% and malignant breast lesions 21.22%. Among the benign breast lesions fibro adenoma was the commonest and among the malignant breast lesion, infiltrating ductal carcinoma was commonest. The peak incidence of benign breast lesion was in 11 to 40 years and malignant lesion in 41 to 70years. Out of 22 cases of infiltrating ductal carcinoma, 27.27% cases showed both ER, PR positivity and 63.64% cases showed both ER, PR negativity. A significant association was seen between histologic grade and ER, PR status.

Conclusion: In our study fibro adenoma was the commonest benign breast lesion and infiltrating ductal carcinoma was the predominant malignant breast lesion. Among the breast cancers, both ER and PR negativity cases were predominant and low grade tumors were showing high ER, PR expression and high grade tumors were showing low ER, PR expression in our study. 

 

DOI: 10.21276/APALM.1378

Author Biographies

Mohan Rao Nandam, Narayana Medical College, Nellore, Andhra Pradesh, India

department of pathology,associate professor

Vissa Shanthi, Narayana Medical College, Nellore, Andhra Pradesh, India

department of pathology,associate professor

References

1.Feraly J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008. Globocan 2008; Int J cancer 2010 Dec 15;127(12):2893-917.

2.Desai M. Role of obstetrician and gynecologist in management of breast lump. J Obstet Gynaecol India 2003; 53:389-91.

3. Sharkey FE, Craig Allred DC, Valente PT, Damjanov I, Linder J’s. Anderson pathology.10thed.st.Louis:Mosby;1996.P.2354-85.

4.Kumar, Abbas, Fausto, Robbins and Cotran Pathologic Basis of Disease. The Breast. 7thed.Philadelphia: Elsevier: P.1119-1154.

5.Merih Guray, Aysegual A shin. Benign breasts Disease; Classification, diagnosis and management; The Oncologist; 2006; 11:435-449.

6.Siddiqui M,Kalyani N, Gill M, pervez S, Muzaffar S, Aziz S, Setna Z, Isar M, Hasan S.Breast disease: a histopathological analysis of 3279 cases at a tertiary care centre in Pakistan . J Park Med Assoc 2003:53(3):94-97.

7.Mansoor I: Profile of female breast lesions in Saudi Arbia. JPMA 2001; 51(7):243-246.

8.Hislop T, Elwood J: Risk Factors for benign breast disease: a 30-year cohort study. Can Med Assoc J 1981; 124(3):283.

9.Parazzini F, La Vecchia C, Franceschi S. Decarli A, Gallus G, Regallo M, Liberati A, Tognoni G. Risk factors for pathologically confirmed benign breast disease. Am J Epidemiol 1984; 120(1):115-122.

10.Ellis H and Cox P J, Breast problems in 1000 consecutive referrals to surgical out –patients. Post grad Med J 1984 Oct: 60(708); 653-656.

11.Oluwule SF, Fadirm OA, odesammi WO. Diseases of the breast in Nigeria. Br J Sur 1987:74(7);582-585

12.Singh UR, Thakur AN, Shah SP, Mishra A. Histo morphological spectrum of breast diseases. J Nep Med Assoc 2000:39:338-3

13.Rasheed A, Sharma S, Mohsin –ul-Rasool, Bashir S, Hafiz A, Bashir N. A three year study of breast lesions in women aged 15-70 years in a Tertiary care hospital. Schloars journal of applied Medical sciences 2014:2(1B):166-168

14.Malik R, Bhardwaj VK. Breast lesions in young female. A 20 year study for significance of early recognition. Indian J path Microbiol 2003;46(4):559-562

15.Kulkarini S et al. Histopathological spectrum of breast lesions with reference to uncommon cases: Obs and Gynae of India Sept –Oct 2009;59(5):444-452

16.Thakral A, Daveshwar M. Histomorphological study of a spectrum of breast diseases n association with immunohistochemistry in Vododara, Gujarat, India. Int J Sci stud 2016:4(9):44-54.

17.Azizun – Nisa, Bhurgi Y, Raza F, kayani N. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Asian Pac J cancer prev 2008:9:553-6.

18.Adedayo AO, Engel JM, Greenlee RT Mukesh BN. Breast cancer subtypes based on ER/PR and Her 2 Expression: Comparison of Clinic pathologic features and survival, Clin Med res. 2009;7:4-13.

19.Suvarchala SB, Nagheshwararao R. Carcinoma Breast-Histopathological and hormone receptors correlation. J Biosci Tech 2011:2; 340-48.

20.Ambroise M, Ghosh M, Mallikarjun VS, Kurian A. Immunohistochemical profile of breast cancer patients at a tertiary care hospital in south India immunohistochemical profile of breast cancer patients tertiary care hospital in south india. Asian pacific J cancer Prev 2011; 12:625-629.

21.Ghosh J, Gupta s, Desai S. Shet T, Radhakrishnan S, Suryavanshi P et al . Estrogen, Progesterone and HER 2 receptor expression in breast tumors of patients and their usage of HER 2 targeted therapy, in a tertiary care centre in India. Indian J cancer 2011; 48:391-6

22. Geehamala k et al. histopathological grade versus Hormone receptor in breast carcinoma IJBR 2015;6(07); 466-471.

Downloads

Published

25-10-2017

How to Cite

1.
Nandam MR, Shanthi V, Grandhi B, Byna SSR, Vydehi BV, Conjeevaram J. Histopathological spectrum of breast lesions in association with Histopathological Grade versus Estrogen receptor and Progesterone receptor status in breast cancers : A Hospital based study. Ann of Pathol and Lab Med [Internet]. 2017 Oct. 25 [cited 2024 Nov. 19];4(5):A496-501. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/apalm1378

Issue

Vol. 4 No. 5 (2017)

Section

Original Article

License

Copyright (c) 2017 Mohan Rao Nandam, Vissa Shanthi, Bhavana Grandhi, Syama Sundara Rao Byna, Bheemaraju Venkata Vydehi, Jyothi Conjeevaram

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).